← Back to Clinical Trials
Recruiting NCT07246057

NCT07246057 Streamlining Telehealth for Expanded PrEP Utilization Through Community Partnerships

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT07246057
Status Recruiting
Phase
Sponsor University of Pennsylvania
Condition HIV
Study Type INTERVENTIONAL
Enrollment 92 participants
Start Date 2026-03-26
Primary Completion 2028-06

Trial Parameters

Condition HIV
Sponsor University of Pennsylvania
Study Type INTERVENTIONAL
Phase N/A
Enrollment 92
Sex ALL
Min Age 16 Years
Max Age N/A
Start Date 2026-03-26
Completion 2028-06
Interventions
STEP-UPPhiladelphia TelePrEP Program Direct-to-Consumer Model

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

Brief Summary

The goal of this study is to learn if STEP-UP (Streamlining Telehealth for Expanded PrEP Utilization through community Partnerships) works to expand access to PrEP for people who could benefit from HIV prevention tools. STEP-UP is an innovative model for PrEP delivery that positions community-based organizations (CBOs) as hubs for PrEP access. STEP-UP builds on the established trust, community expertise, and comprehensive services of CBOs serving individuals who could benefit from HIV prevention tools, integrating telehealth PrEP delivery into their existing infrastructure through partnership with a local telehealth PrEP program. By enabling CBOs to offer telePrEP navigation within their array of health and social services, STEP-UP creates accessible, comprehensive care centers that address barriers to PrEP access faced by individuals who could benefit from HIV prevention tools. The main questions it aims to answer are: 1. Is STEP-UP acceptable and feasible to implement in community settings? 2. Does STEP-UP increase PrEP prescription rates compared to the existing direct-to-consumer telehealth model? Researchers will compare people who receive telehealth PrEP services through STEP-UP at community-based organizations to those who access telehealth PrEP through the existing direct-to-consumer telehealth model. Some participants will: 1. Complete surveys about their experiences with the program 2. Participate in an interview to share their perspectives and feedback about the program.

Eligibility Criteria

Inclusion - Client Interviews: 1. At least 18 years of age or older 2. Have received services or participated in programming at a partner CBO in the past 12 months 3. Currently live in the Philadelphia metropolitan area 4. Able to provide informed consent Staff Interviews: 1. At least 18 years of age or older 2. Currently employed at Philadelphia telePrEP Program or a partner CBO 3. Serve in a client-facing role (e.g., outreach specialists) or leadership position (e.g., program coordinators) at one of the aforementioned organizations 4. Have been in their current role for at least 6 months 5. Able to provide informed consent Client Surveys: 1. At least 16 years of age or older 2. Have engaged with a Community TelePrEP Navigator through a partner site CBO to schedule a telehealth appointment with a PrEP provider 3. Currently live in the Philadelphia metropolitan area 4. Able to provide informed consent Exclusion- 1. Under 16 years of age (clients surveys) or under 18 years of age (staff

Related Trials

Related Intelligence Guides

In-depth guides covering this condition's trials, eligibility, and what to expect.

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology